摘要 |
Provided are methods and compositions for treating ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example, neovascular age-related macular degeneration. The selectivity and sensitivity of, for example, a photodynamic therapy (PDT)-based approach can be enhanced by combining the PDT with an ansamycin analog or heat shock protein 90 inhibitor, for example, 17-allylamino-17-demethoxygeldanamycin. |
申请人 |
MASSACHUSETTS EYE AND EAR INFIRMARY;POULAKI, VASSILIKI;MILLER, JOAN, W.;GRAGOUDAS, EVANGELOS, S. |
发明人 |
POULAKI, VASSILIKI;MILLER, JOAN, W.;GRAGOUDAS, EVANGELOS, S. |